Molly C. McCloskey

Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection

Samuel L.M. Arnold, Ryan Choi, Matthew A. Hulverson et al. · The Journal of Infectious Diseases · 2017 · 59 citations · Full text

Translational Medicine, Preclinical Drug Evaluation, Cryptosporidium Infection +14

Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis

Joachim Müller, Adriana Aguado-Martínez, Luis Miguel Ortega‐Mora et al. · Journal of Antimicrobial Chemotherapy · 2017 · 48 citations · Full text

Screening of the Pathogen Box for inhibitors with dual efficacy against Giardia lamblia and Cryptosporidium parvum

Kelly M. Hennessey, Ilse Rogiers, Han-Wei Shih et al. · PLoS neglected tropical diseases · 2018 · 47 citations · Full text

Parasitic Disease, Pathogen Detection, Antiparasitic Agent +18

Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis

Matthew A. Hulverson, Ryan Choi, Samuel L.M. Arnold et al. · International Journal for Parasitology · 2017 · 37 citations · Full text

Medicine, Pathology, Animal Therapy +3

Development of 5-Aminopyrazole-4-carboxamide-based Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy

Wenlin Huang, Matthew A. Hulverson, Ryan Choi et al. · Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Antiparasitic Agent +13